Table 1.

CC versus HDT

Study
No. of patients
EFS, mo CC/HDT
OS, mo CC/HDT
P
IFM 9018   200   18/28   44/57   .03  
MRC VII26   407   20/32   42/54   .04  
Little Rock SWOG case control19   229   22/49   49/62+   .01  
Nordic20   548   27/32   44/NR   .01  
Torino21   142   18/34   48/56+   .01  
PETHEMA25   164   34/43   56/62   NS  
MAG 9124 
 		 190
 		 19/24
 		 50/55
 		 NS
 
Study
No. of patients
EFS, mo CC/HDT
OS, mo CC/HDT
P
IFM 9018   200   18/28   44/57   .03  
MRC VII26   407   20/32   42/54   .04  
Little Rock SWOG case control19   229   22/49   49/62+   .01  
Nordic20   548   27/32   44/NR   .01  
Torino21   142   18/34   48/56+   .01  
PETHEMA25   164   34/43   56/62   NS  
MAG 9124 
 		 190
 		 19/24
 		 50/55
 		 NS
 

NR indicates not reached; NS, not significant.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal